cladribine has been researched along with Chromosome Deletion in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campo, E; MartÃnez-Trillos, A; Matutes, E | 1 |
| Setoodeh, R; Zhang, L | 1 |
2 review(s) available for cladribine and Chromosome Deletion
| Article | Year |
|---|---|
Hairy cell leukaemia-variant: Disease features and treatment.
Topics: Aged; Antigens, CD; Antineoplastic Agents; B-Lymphocytes; Bone Marrow; Chromosome Deletion; Chromosomes, Human, Pair 17; Cladribine; Humans; Immunoglobulin Heavy Chains; Leukemia, Hairy Cell; Lymphocytosis; Male; MAP Kinase Kinase 1; Mutation; Rituximab; Spleen; Splenomegaly; Survival Analysis; Tumor Suppressor Protein p53 | 2015 |
Secondary T-lymphoblastic leukemia in a patient with hairy cell leukemia following cladribine therapy: report of an extremely rare case and review of the literature.
Topics: Antineoplastic Agents; Chromosome Deletion; Chromosomes, Human, Pair 10; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 9; Cladribine; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Neoplasms, Second Primary; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Translocation, Genetic | 2012 |